日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size

CD4+细胞计数≥800个/mm³时开始抗逆转录病毒治疗与较低的人类免疫缺陷病毒(HIV)病毒库大小相关。

Rasmussen, Thomas A; Ahuja, Sunil K; Kuwanda, Locadiah; Vjecha, Michael J; Hudson, Fleur; Lal, Luxshimi; Rhodes, Ajantha; Chang, Judy; Palmer, Sarah; Auberson-Munderi, Paula; Mugerwa, Henry; Wood, Robin; Badal-Faesen, Sharlaa; Pillay, Sandy; Mngqibisa, Rosie; LaRosa, Alberto; Hildago, Jose; Petoumenos, Kathy; Chiu, Chris; Lutaakome, Joseph; Kitonsa, Jonathan; Kabaswaga, Esther; Pala, Pietro; Ganoza, Carmela; Fisher, Katie; Chang, Christina; Lewin, Sharon R; Wright, Edwina J

Phylogenetic analysis of HIV-1 shows frequent cross-country transmission and local population expansions

HIV-1的系统发育分析表明,其频繁发生跨国传播和局部人口扩张。

Bennedbæk, Marc; Zhukova, Anna; Tang, Man-Hung Eric; Bennet, Jaclyn; Munderi, Paula; Ruxrungtham, Kiat; Gisslen, Magnus; Worobey, Michael; Lundgren, Jens D; Marvig, Rasmus L

Dyslipidemias and cardiovascular risk scores in urban and rural populations in north-western Tanzania and southern Uganda

坦桑尼亚西北部和乌干达南部城市和农村人口的血脂异常和心血管风险评分

Kavishe, Bazil; Vanobberghen, Fiona; Katende, David; Kapiga, Saidi; Munderi, Paula; Baisley, Kathy; Biraro, Samuel; Mosha, Neema; Mutungi, Gerald; Mghamba, Janneth; Hughes, Peter; Smeeth, Liam; Grosskurth, Heiner; Peck, Robert

Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30-49 vs ≥50 mL/min

比较基线肌酐清除率为 30-49 mL/min 与 ≥50 mL/min 的 HIV 感染成人接受标准剂量(300 mg/天)含拉米夫定抗逆转录病毒疗法后肌酐清除率随时间的变化以及新发不良事件的发生情况。

Ross, Lisa L; Walker, A Sarah; Lou, Yu; Tenorio, Allan R; Gibb, Diana M; Double, Julia; Gilks, Charles; McCoig, Cynthia C; Munderi, Paula; Musoro, Godfrey; Kityo, Cissy M; Grosskurth, Heiner; Hakim, James; Mugyenyi, Peter N; Cutrell, Amy; Perger, Teodora; Shaefer, Mark S

Prevalence of high blood pressure and associated factors among adolescents and young people in Tanzania and Uganda

坦桑尼亚和乌干达青少年及青年高血压患病率及相关因素

Nsanya, Mussa K; Kavishe, Bazil B; Katende, David; Mosha, Neema; Hansen, Christian; Nsubuga, Rebecca N; Munderi, Paula; Grosskurth, Heiner; Kapiga, Saidi

Switching at Low HIV-1 RNA into Fixed Dose Combinations: TDF/FTC/RPV is non-inferior to TDF/FTC/EFV in first-line suppressed patients living with HIV

在HIV-1 RNA水平较低时换用固定剂量复方制剂:对于一线治疗且病毒载量受到抑制的HIV感染者,TDF/FTC/RPV方案不劣于TDF/FTC/EFV方案。

Munderi, Paula; Were, Edwin; Avihingsanon, Anchalee; Mbida, Pascale A M; Mohapi, Lerato; Moussa, Samba B; Jansen, Marjolein; Bicer, Ceyhun; Mohammed, Perry; van Delft, Yvon

Expert consensus statement on the science of HIV in the context of criminal law

关于艾滋病毒科学在刑法背景下的专家共识声明

Barré-Sinoussi, Françoise; Abdool Karim, Salim S; Albert, Jan; Bekker, Linda-Gail; Beyrer, Chris; Cahn, Pedro; Calmy, Alexandra; Grinsztejn, Beatriz; Grulich, Andrew; Kamarulzaman, Adeeba; Kumarasamy, Nagalingeswaran; Loutfy, Mona R; El Filali, Kamal M; Mboup, Souleymane; Montaner, Julio Sg; Munderi, Paula; Pokrovsky, Vadim; Vandamme, Anne-Mieke; Young, Benjamin; Godfrey-Faussett, Peter

Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial

在乌干达,对接受抗逆转录病毒治疗且病情稳定的 HIV 感染成人停止复方新诺明预防性治疗(COSTOP):一项随机安慰剂对照试验

Anywaine, Zacchaeus; Levin, Jonathan; Kasirye, Ronnie; Lutaakome, Joseph Kayiira; Abaasa, Andrew; Nunn, Andrew; Grosskurth, Heiner; Munderi, Paula

Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations

在资源匮乏地区大规模提高抗逆转录病毒疗法依从性:干预措施和建议探讨

Haberer, Jessica E; Sabin, Lora; Amico, K Rivet; Orrell, Catherine; Galárraga, Omar; Tsai, Alexander C; Vreeman, Rachel C; Wilson, Ira; Sam-Agudu, Nadia A; Blaschke, Terrence F; Vrijens, Bernard; Mellins, Claude A; Remien, Robert H; Weiser, Sheri D; Lowenthal, Elizabeth; Stirratt, Michael J; Sow, Papa Salif; Thomas, Bruce; Ford, Nathan; Mills, Edward; Lester, Richard; Nachega, Jean B; Bwana, Bosco Mwebesa; Ssewamala, Fred; Mbuagbaw, Lawrence; Munderi, Paula; Geng, Elvin; Bangsberg, David R

Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial.

START 试验中的系统性炎症、凝血和临床风险

Baker Jason V, Sharma Shweta, Grund Birgit, Rupert Adam, Metcalf Julia A, Schechter Mauro, Munderi Paula, Aho Inka, Emery Sean, Babiker Abdel, Phillips Andrew, Lundgren Jens D, Neaton James D, Lane H Clifford